Trial Profile
A study investigating the effect of therapeutic and supratherapeutic doses of lenalidomide on QTc intervals in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Moxifloxacin
- Indications Haematological malignancies; Multiple myeloma
- Focus Adverse reactions
- 05 Dec 2015 New trial record